Viewing Study NCT00940160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-06-14 @ 10:00 AM
Study NCT ID: NCT00940160
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2009-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CQAX576A2107
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: External Affairs
Old Organization: Novartis Pharmaceuticals

Collaborators